GFX Biocapital SRL
GFX Biocapital reported total assets of 808,612 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jun 2026).
By total assets for 2025, GFX Biocapital ranks among the 20,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of GFX Biocapital shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -99 % Total assets +34 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
GFX Biocapital's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 89,904 € | ||||
| Equity | 6,000 € | ||||
| Cash | 721,605 € | ||||
| EBITDA | 133,890 € | ||||
| Total assets | 808,612 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jun 2026
- Year ended 31 Dec 2024filed on 17 Sep 2025
- Year ended 31 Dec 2023filed on 18 Jun 2024
- Year ended 31 Dec 2022filed on 21 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
GFX Biocapital's financial analysis
- Solvency0.7%sector median: 50.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of GFX Biocapital
GFX Biocapital's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0736.965.814
- VAT number
- BE0736965814
- Peppol
- Registered · 0208:0736965814 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Oct 2019
- Registered office
- 1050 Ixelles
- Latest accounts
- 2025 · filed on 08 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
GFX Biocapital (SRL) has been based in Ixelles since 2019, active in: business and other management consultancy activities. For 2025, it reports a net profit of 89,904 € and equity of 6,000 €; its revenue is not published. Its solvency stands at 0.7%, below the median of its sector (50.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to GFX Biocapital
Companies in the same business, of comparable size and area, outside its group.
- Sandor Consulting Business and other management consultancy activities Bertem · balance sheet 665,205 €
- Jacobs Andre Advies en Consulting Business and other management consultancy activities Malmedy · balance sheet 8,426 €
- MiTiBel Business and other management consultancy activities Lochristi · balance sheet 62,393 €
- DA Consult Business and other management consultancy activities Thimister-Clermont · balance sheet 893,266 €
- E.Y.C.S.S. Business and other management consultancy activities Brussels · balance sheet 15,367 €
- Machtelinckx@Law Business and other management consultancy activities Antwerp · balance sheet 754,091 €
- Sapientes Business and other management consultancy activities Boortmeerbeek · balance sheet 767,853 €
- Balora Invest Business and other management consultancy activities Bree · balance sheet 967,836 €
Frequently asked questions about GFX Biocapital
What is the revenue of GFX Biocapital?
GFX Biocapital files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of GFX Biocapital?
In Belgium, the VAT number is the company number prefixed with BE: BE0736965814 for GFX Biocapital, if the company is VAT-registered. Its company number (CBE) is 0736.965.814.
Where is the registered office of GFX Biocapital?
According to the CBE register, the registered office of GFX Biocapital is in 1050 Ixelles.
What is the equity of GFX Biocapital?
At the close of the 2025 financial year, the equity of GFX Biocapital amounts to 6,000 €, a solvency of 0.7% of total assets.
Who manages GFX Biocapital?
The register lists 1 active mandates at GFX Biocapital. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is GFX Biocapital within its sector?
By total assets for 2025, GFX Biocapital ranks among the 20,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.
The full file of GFX Biocapital
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →